Association of PBEF gene polymorphisms with acute lung injury, sepsis, and pneumonia in a northeastern Chinese population

Abstract Background: Several studies have suggested that pre-B-cell colony-enhancing factor (PBEF) gene polymorphisms are associated with susceptibility to and prognosis of acute lung injury (ALI) in several populations of Caucasians. The aim of this study was to detect the distribution of PBEF alleles and to evaluate any potential relationship between PBEF polymorphisms and ALI, sepsis, and pneumonia in the Han population of Northeast China. Methods: Genotyping of two PBEF promoter single-nucleotide polymorphisms (SNPs), rs61330082 (C–1535T) and rs9770242 (T–1001G), were performed in patients with ALI (n=130), sepsis alone (n=107), bacterial pneumonia (n=195) and 150 healthy volunteers using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: We found no variation in the T-1001G allele of PBEF. The homozygous TT genotype was the only genotype. This result is different from that observed in Caucasians. The frequency of the -1543T allele was lower in patients with ALI and sepsis than that in healthy subjects ALI vs. healthy controls: OR=0.60, 95% CI 0.43–0.84, p=0.003; and sepsis vs. healthy controls: OR=0.69, 95% CI 0.49–0.99, p=0.04, respectively). The frequency of TT genotype of -1543T was significantly lower in patients with ALI and sepsis than in healthy subjects (ALI vs. healthy controls: OR=0.23, 95% CI 0.10–0.54, p=0.001; and sepsis vs. healthy controls: OR=0.36, 95% CI 0.15–0.83, p=0.02, respectively). Conclusions: This study suggested that -1543T allele might be a protective factor for ALI and sepsis, but it apparently had no connection with pneumonia in northeastern Chinese Han patients.

[1]  S. Ye,et al.  Critical role of PBEF expression in pulmonary cell inflammation and permeability , 2009, Cell biology international.

[2]  Wang Kai Relationship between genetic polymorphism of internal organs amoxicillin and type 2 diabetes mellitus , 2008 .

[3]  Hidetoshi Inoko,et al.  Single nucleotide polymorphism detection by polymerase chain reaction-restriction fragment length polymorphism , 2007, Nature Protocols.

[4]  M. Matthay,et al.  Pulmonary barriers to pneumonia and sepsis , 2007, Nature Medicine.

[5]  D. Christiani,et al.  Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome* , 2007, Critical care medicine.

[6]  S. Tonstad,et al.  Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization , 2007, Circulation.

[7]  H. Tilg,et al.  Visfatin , an Adipocytokine with Proinflammatory and Immunomodulating Properties 1 , 2007 .

[8]  Joe G. N. Garcia,et al.  Genomic insights into acute inflammatory lung injury. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[9]  C. Fielding,et al.  Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[10]  J. Gómez-Reino,et al.  Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[11]  S. Ye,et al.  Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. , 2005, Microvascular research.

[12]  E. Moore,et al.  Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation , 2005, Journal of leukocyte biology.

[13]  Reinhard Guthke,et al.  Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. , 2005, European journal of dermatology : EJD.

[14]  J. Pickering,et al.  Pre–B-Cell Colony–Enhancing Factor Regulates NAD+-Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell Maturation , 2005, Circulation research.

[15]  T. Standiford,et al.  Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. , 2005, American journal of respiratory and critical care medicine.

[16]  J. Garcia,et al.  Searching for candidate genes in acute lung injury: SNPs, Chips and PBEF. , 2005, Transactions of the American Clinical and Climatological Association.

[17]  J. Marshall,et al.  Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. , 2004, The Journal of clinical investigation.

[18]  J. Vincent,et al.  Epidemiology and outcome of acute respiratory failure in intensive care unit patients , 2003, Critical care medicine.

[19]  D. Gigot,et al.  Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.

[20]  S. Ognjanovic,et al.  Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. , 2002, American journal of obstetrics and gynecology.

[21]  S. Ognjanovic,et al.  Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. , 2001, Journal of molecular endocrinology.

[22]  L. Tashima,et al.  Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. , 2000, American journal of obstetrics and gynecology.

[23]  R. Maunder,et al.  Clinical risks for development of the acute respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.

[24]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[25]  I McNiece,et al.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.

[26]  R. Bone Guidelines for the Use of Innovative Therapies in Sepsis , 1993 .